Search Results 261-270 of 19184 for prostate cancer
... prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the ...
The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...
... prostate cancer. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as bicalutamide, may lessen the amount of androgens made ...
XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · More about research ...
Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic ...
Clinical Trials · A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer · More about research at Mayo ...
When Bruce McVety's prostate cancer returned after a seven-year remission, his doctor suggested he go to Mayo Clinic to receive a test that wasn't available ...
Jason. Exercise is good for the body, and that holds true for men with prostate cancer. 06:11. Mitchell Humphreys, M.D.. Urology. Mayo Clinic. "What we found is ...
Prostate cancer: Does PSA level affect prognosis? What is prostate cancer ... Prostate cancer metastasis: Where does prostate cancer spread? Prostate ...
2009 European Randomized Study of Screening for Prostate Cancer and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; 2013 American Urological ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.